A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study

Overview of attention for article published in British Journal of Haematology, September 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients w... https://t.co/trRB4R23ds PM

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.